These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8701941)

  • 21. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
    Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
    Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor.
    Hilbert L; Gaucher C; Mazurier C
    Br J Haematol; 1995 Dec; 91(4):983-90. PubMed ID: 8547152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
    Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
    Kang M; Wilson L; Kermode JC
    Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.
    Sugimoto M; Ricca G; Hrinda ME; Schreiber AB; Searfoss GH; Bottini E; Ruggeri ZM
    Biochemistry; 1991 May; 30(21):5202-9. PubMed ID: 2036386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion.
    Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y
    Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
    Moriki T; Murata M; Kitaguchi T; Anbo H; Handa M; Watanabe K; Takahashi H; Ikeda Y
    Blood; 1997 Jul; 90(2):698-705. PubMed ID: 9226170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
    Meyer D; Fressinaud E; Hilbert L; Ribba AS; Lavergne JM; Mazurier C
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):349-64. PubMed ID: 11686104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
    Carew JA; Quinn SM; Stoddart JH; Lynch DC
    J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF.
    Hilbert L; Gaucher C; Mazurier C
    Blood; 1995 Aug; 86(3):1010-8. PubMed ID: 7620154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.
    Murata M; Ware J; Ruggeri ZM
    J Biol Chem; 1991 Aug; 266(23):15474-80. PubMed ID: 1651333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin.
    Sixma JJ; Schiphorst ME; Verweij CL; Pannekoek H
    Eur J Biochem; 1991 Mar; 196(2):369-75. PubMed ID: 1901037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Peng Y; Berndt MC; Cruz MA; López JA
    Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
    Li CQ; Dong JF; López JA
    Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.